SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/18/21 AVROBIO, Inc. 10-K 12/31/20 73:9.1M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.29M 2: EX-10.19 Material Contract HTML 74K 3: EX-10.20 Material Contract HTML 78K 4: EX-10.25 Material Contract HTML 104K 5: EX-21.1 Subsidiaries List HTML 22K 6: EX-23.1 Consent of Expert or Counsel HTML 26K 7: EX-31.1 Certification -- §302 - SOA'02 HTML 30K 8: EX-31.2 Certification -- §302 - SOA'02 HTML 30K 9: EX-32.1 Certification -- §906 - SOA'02 HTML 25K 16: R1 Document and Entity Information HTML 92K 17: R2 Consolidated Balance Sheets HTML 87K 18: R3 Consolidated Balance Sheets (Parenthetical) HTML 39K 19: R4 Consolidated Statements of Operations and HTML 56K Comprehensive Loss 20: R5 Consolidated Statements of Stockholders' Equity HTML 70K 21: R6 Consolidated Statements of Stockholders' Equity HTML 25K (Parenthetical) 22: R7 Consolidated Statements of Cash Flows HTML 94K 23: R8 Nature of the Business HTML 27K 24: R9 Summary of Significant Accounting Policies HTML 73K 25: R10 License Agreements HTML 43K 26: R11 Fair Value of Financial Assets and Liabilities HTML 78K 27: R12 Supplemental Balance Sheet Information HTML 110K 28: R13 Commitments and Contingencies HTML 45K 29: R14 Common Stock HTML 62K 30: R15 Stock-Based Compensation HTML 143K 31: R16 401(k) Savings Plan HTML 28K 32: R17 Income Taxes HTML 114K 33: R18 Net Loss per Share HTML 43K 34: R19 Related Party Transactions HTML 26K 35: R20 Summary of Significant Accounting Policies HTML 127K (Policies) 36: R21 Summary of Significant Accounting Policies HTML 28K (Tables) 37: R22 Fair Value of Financial Assets and Liabilities HTML 78K (Tables) 38: R23 Supplemental Balance Sheet Information (Tables) HTML 115K 39: R24 Commitments and Contingencies (Tables) HTML 37K 40: R25 Common Stock (Tables) HTML 60K 41: R26 Stock-Based Compensation (Tables) HTML 134K 42: R27 Income Taxes (Tables) HTML 107K 43: R28 Net Loss per Share (Tables) HTML 42K 44: R29 Nature of the Business - Additional Information HTML 28K (Detail) 45: R30 Summary of Significant Accounting Policies - HTML 65K Additional Information (Detail) 46: R31 Summary of Significant Accounting Policies - HTML 32K Schedule of Property and Equipment Estimated Useful Life (Detail) 47: R32 License Agreements - Additional Information HTML 89K (Detail) 48: R33 Fair Value of Financial Assets and Liabilities - HTML 31K Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) 49: R34 Fair Value of Financial Assets and Liabilities - HTML 23K Additional Information (Detail) 50: R35 Supplemental Balance Sheet Information - Summary HTML 37K of Prepaid Expenses and Other Current Assets (Detail) 51: R36 Supplemental Balance Sheet Information - Summary HTML 36K of Property and Equipment, Net (Detail) 52: R37 Supplemental Balance Sheet Information - HTML 24K Additional Information (Detail) 53: R38 Supplemental Balance Sheet Information - Summary HTML 24K of Restricted Cash (Detail) 54: R39 Supplemental Balance Sheet Information - Summary HTML 33K of Accrued Expenses (Detail) 55: R40 Commitments and Contingencies - Additional HTML 42K Information (Detail) 56: R41 Commitments and Contingencies - Summary of Future HTML 36K Minimum Lease Payments Due Under Operating Leases (Detail) 57: R42 Common Stock - Additional Information (Detail) HTML 61K 58: R43 Common Stock - Summary of Common Stock Reserved HTML 40K for Future Issuance (Detail) 59: R44 Stock-Based Compensation - Additional Information HTML 81K (Detail) 60: R45 Stock-Based Compensation - Summary of Assumptions HTML 30K that Used to Determine Grant-Date Fair Value of Stock Options Granted to Employees and Members of Board (Detail) 61: R46 Stock-Based Compensation - Summary of Stock Option HTML 56K Activity (Detail) 62: R47 Stock-Based Compensation - Summary of Restricted HTML 32K Stock Award and Restricted Stock Unit Activity (Detail) 63: R48 Stock-Based Compensation - Schedule of Stock-based HTML 29K Compensation Expense (Detail) 64: R49 401(k) Savings Plan - Additional Information HTML 29K (Detail) 65: R50 Income Taxes - Additional Information (Detail) HTML 67K 66: R51 Income Taxes - Schedule of Reconciliation of HTML 41K Income Tax Expense (Benefit) (Detail) 67: R52 Income Taxes - Schedule of Deferred Tax Assets and HTML 47K Liabilities (Detail) 68: R53 Net Loss per Share - Schedule of Dilutive Common HTML 29K Stock Equivalents Excluded from Computation of Diluted Net Loss per Share (Detail) 69: R54 Related Party Transactions - Additional HTML 39K Information (Detail) 71: XML IDEA XML File -- Filing Summary XML 127K 15: XML XBRL Instance -- avro-10k_20201231_htm XML 1.56M 70: EXCEL IDEA Workbook of Financial Reports XLSX 85K 11: EX-101.CAL XBRL Calculations -- avro-20201231_cal XML 125K 12: EX-101.DEF XBRL Definitions -- avro-20201231_def XML 409K 13: EX-101.LAB XBRL Labels -- avro-20201231_lab XML 1.07M 14: EX-101.PRE XBRL Presentations -- avro-20201231_pre XML 756K 10: EX-101.SCH XBRL Schema -- avro-20201231 XSD 154K 72: JSON XBRL Instance as JSON Data -- MetaLinks 308± 476K 73: ZIP XBRL Zipped Folder -- 0001564590-21-014190-xbrl Zip 570K
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of AVROBIO, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of his or her knowledge that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: March 18, 2021 |
|
By: |
|
/s/ Geoff MacKay |
|
|
|
|
|
|
|
|
|
Chief Executive Officer (Principal Executive Officer) |
Date: March 18, 2021 |
|
By: |
|
/s/ Erik Ostrowski |
|
|
|
|
|
|
|
|
|
Chief Financial Officer (Principal Financial Officer) |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/18/21 | 8-K, S-8 | ||
For Period end: | 12/31/20 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/24 AVROBIO, Inc. S-4/A 80:15M Donnelley … Solutions/FA 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA 3/14/24 AVROBIO, Inc. 10-K 12/31/23 80:9.4M Donnelley … Solutions/FA 2/14/24 AVROBIO, Inc. S-4 91:25M Donnelley … Solutions/FA 3/23/23 AVROBIO, Inc. 10-K 12/31/22 82:10M Donnelley … Solutions/FA 3/17/22 AVROBIO, Inc. 10-K 12/31/21 78:9.1M ActiveDisclosure/FA 3/18/21 AVROBIO, Inc. S-8 3/18/21 3:81K Donnelley … Solutions/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/05/20 AVROBIO, Inc. 10-Q 9/30/20 61:6.1M ActiveDisclosure/FA 8/06/20 AVROBIO, Inc. 10-Q 6/30/20 60:6.4M ActiveDisclosure/FA 6/09/20 AVROBIO, Inc. 8-K:5,9 6/04/20 2:66K ActiveDisclosure/FA 3/16/20 AVROBIO, Inc. 10-K 12/31/19 85:8.4M ActiveDisclosure/FA 12/20/19 AVROBIO, Inc. S-8 12/20/19 4:170K Donnelley … Solutions/FA 3/25/19 AVROBIO, Inc. S-8 3/25/19 4:96K Donnelley … Solutions/FA 3/25/19 AVROBIO, Inc. 10-K 12/31/18 85:7.2M Donnelley … Solutions/FA 12/21/18 AVROBIO, Inc. 8-K:5,7,9 12/17/18 3:177K Donnelley … Solutions/FA 6/25/18 AVROBIO, Inc. 8-K:5,9 6/20/18 3:148K Donnelley … Solutions/FA 6/11/18 AVROBIO, Inc. S-1/A¶ 18:5.4M Donnelley … Solutions/FA 6/01/18 AVROBIO, Inc. S-1/A 3:497K Donnelley … Solutions/FA 5/25/18 AVROBIO, Inc. S-1 15:5.5M Donnelley … Solutions/FA |